paroxysmal nocturnal hemoglobinuria

Pharma

AZ's rare disease rising star Ultomiris snags 3rd FDA nod

The FDA has approved AstraZeneca's Ultomiris to treat generalized myasthenia gravis, an autoimmune neuromuscular disorder.
Kevin Dunleavy Apr 28, 2022 9:15am

Lilly-Innovent, Biogen-Eisai, FDA and more—Fierce Pharma Asia

Feb 11, 2022 6:22am

NICE recommends Sobi's rare disease drug Aspaveli

Dec 9, 2021 9:04am

Even during pandemic, FDA approvals remain on a rapid pace

Jul 6, 2021 11:27am

NICE gives a second nod to Alexion's pricey Ultomiris

May 20, 2021 7:50am

Apellis gets its shot at Alexion’s Soliris with new PNH approval

May 14, 2021 5:15pm